Advertisement

 

 

ICAAC 2012: Influenza Treatment in Infants

ICAAC 2012: Influenza Treatment in Infants
Advertisement
Share on FacebookTweet about this on TwitterShare on LinkedIn

The Particulars: Among children aged 2 and younger, influenza-associated morbidity is high. It is not clear, however, how the clinical complications, anti-viral treatment patterns, and healthcare use of infants aged 1 or younger during the H1N1 2009 pandemic compares with those of previous pre-pandemic seasons.

Data Breakdown: A retrospective analysis compared several factors in the 2009 H1N1 pandemic with those in the three previous seasons. Among the findings:

Take Home Pearls: During the 2009 H1N1 pandemic season, infants aged 1 or younger appeared to have been four times more likely to receive AVT than in previous pre-pandemic seasons. Hospitalization and complication risks appear to be lower with use of AVT in this patient population.

Readings & Resources (click to view)

For more information on these studies and others that were presented at ICAAC 2012, go to www.icaac.org.

2 Comments

  1. In June 2009, the World Health Organization declared the new strain of swine-origin H1N1 as a pandemic. This strain is often called swine flu by the public media. This novel virus spread worldwide and had caused about 17,000 deaths by the start of 2010. On August 10, 2010, the World Health Organization declared the H1N1 influenza pandemic over, saying worldwide flu activity had returned to typical seasonal patterns.,^

    My personal blog page
    http://www.picturesofherpes.co/index.php

    Reply
  2. I was with the Canadian Forces in 2009, was ordered to get the H1N1 shot (AREPANRIX by GSK GlaxoSmithKline) and had an adverse reaction to the vaccine. I received PERMANENT neurological, cardiovascular, gastrointestinal, and respiratory symptoms: dizziness, vertigo, irregular heart rhythms, shortness of breath, muscle weakness and pain, and numbness in hands and feet. My physical fitness changed from special forces fit to that of a 70 year old in a matter of days. Prior to the vaccination the Department of National Defence (DND) provided information advising side effects “having mild chills and fever a few days following the shot means it is working”, and “There is a 1 in 1,000,000 chance of acquiring a serious neurological complication”. According to GSKs product information provided by Health Canada, “neurological disorders” are “very rare (may occur with up to 1 in 10,000 doses)” and “if any of these side effects occur, please tell your doctor or nurse immediately” which differs from the information provided to soldiers. The DND also stated “It is not a live vaccine so it cannot give you the flu”. According to Dr. Danuta Skowronski, an epidemiologist and an influenza expert at the B.C. Centre for Disease Control, “In the early weeks of the pandemic that people who got the flu shot (H1N1) for 2008-09 winter seemed to be more likely to get infected with the pandemic virus than people who hadn’t received the shot”. Another study linked narcolepsy, a neurological disorders to the H1N1 vaccine, “Narcolepsy in association with pandemic influenza vaccination”, September 2012, European Centre for Disease Prevention and Control. You may also query the National Vaccine Information Center database of adverse reactions to vaccines (VAERS) which includes more than 11,465 events (adverse reactions) to the H1N1 vaccine, 3,390 symptoms and 61,500 reactions (more than 5 reactions per record). In the UK, the “FINAL PUBLIC SUMMARY – UK Suspected Adverse Reaction Analysis, Swine Flu (H1N1) Vaccines – Celevanpan and Pandemrix, 26 March 2010” details more than 8,600 suspected reactions classified into 650 reaction names. Other information to consider is from Richard Warrington, President of the Canadian Society of Allergy and Clinical Immunology, “Vaccination with Arepanrix has led to far more reports of anaphylaxis or significant allergic reactions than is normally expected for a flu vaccine.” You may also ask your doctor and other Health care workers if they received the H1N1 vaccination and if they plan to remain up to date with all vaccinations. Reports from Canada, US, India, Hong Kong and other countries note a 50% vaccination rate among those who recommend and administer the immunization. According to Fox News “Most said they would pass on the H1N1 shot … because they were afraid of side effects and doubted how safe and effective it would be.” I asked my doctor and he didn’t hesitate in saying “no way”. Be informed and please choose wisely if you do plan to have your next flu shot or vaccination.

    Reply

Trackbacks/Pingbacks

  1. ICAAC 2012 Conference Coverage | Physician's Weekly - [...] Influenza Treatment in Infants [...]

Submit a Comment

Your email address will not be published. Required fields are marked *

7 − two =

[ HIDE/SHOW ]